M&A Deal Summary

NAMSA Acquires Reimbursement Strategies

On January 7, 2019, NAMSA acquired life science company Reimbursement Strategies

Acquisition Highlights
  • This is NAMSA’s 1st transaction in the Life Science sector.
  • This is NAMSA’s 1st transaction in the United States.
  • This is NAMSA’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2019-01-07
Target Reimbursement Strategies
Sector Life Science
Buyer(s) NAMSA
Deal Type Add-on Acquisition

Target

Reimbursement Strategies

St. Paul, Minnesota, United States
Reimbursement Strategies LLC is a Minneapolis-based consultancy focused on reimbursement, health economics and market access for the international life science industry.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

NAMSA

Northwood, Ohio, United States
Category Company
Founded 1967
Sector Medical Products
DESCRIPTION

NAMSA is a medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. NAMSA was established in 1967 and is based in Northwood, Ohio.

DEAL STATS #
Overall 1 of 9
Sector (Life Science) 1 of 6
Type (Add-on Acquisition) 1 of 9
State (Minnesota) 1 of 2
Country (United States) 1 of 5
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-03 NAMSA - Sterility Assurance Monitoring Products Division

United States

NAMSA - Sterility Assurance Monitoring Products Division is a manufacturer of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. Its domestic and international market segments include pharmaceutical, medical device, contract sterilizers, laboratories, health care, dental, food and beverage, and biotech companies.

Sell $14M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-05 Syntactx

New York, New York, United States

Syntactx is the ideal clinical research partner with significant expertise in complex interventional medical device and pharmaceutical trials across multiple therapeutic areas.

Buy -
Mergr

Product

Company

Legal